VICARIOUS SURGICAL INC-A (RBOT) Stock Overview
NYSE:RBOT - US92561V2088 - Common Stock
RBOT Key Statistics, Chart & Performance
The current stock price of RBOT is 5.69 USD. In the past month the price decreased by -36.21%. In the past year, price decreased by -1.39%.
RBOT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.13 | 231.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 58 | 167.36B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.89 | 158.87B | ||
| SYK | STRYKER CORP | 30.53 | 149.98B | ||
| MDT | MEDTRONIC PLC | 16.8 | 119.16B | ||
| BDX | BECTON DICKINSON AND CO | 13.48 | 55.14B | ||
| IDXX | IDEXX LABORATORIES INC | 53.54 | 51.44B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.49 | 47.52B | ||
| RMD | RESMED INC | 29.01 | 40.56B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.25 | 34.58B | ||
| DXCM | DEXCOM INC | 47.36 | 31.57B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.63 | 26.89B |
Related stock screener links
About RBOT
Company Profile
Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Waltham, Massachusetts and currently employs 123 full-time employees. The company went IPO on 2020-09-04. The firm is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.
Company Info
VICARIOUS SURGICAL INC-A
78 Fourth Avenue
Waltham MASSACHUSETTS US
CEO: David Chu
Employees: 121
Phone: 16178681700
VICARIOUS SURGICAL INC-A / RBOT FAQ
What is the stock price of VICARIOUS SURGICAL INC-A today?
The current stock price of RBOT is 5.69 USD. The price decreased by -0.35% in the last trading session.
What is the ticker symbol for VICARIOUS SURGICAL INC-A stock?
The exchange symbol of VICARIOUS SURGICAL INC-A is RBOT and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is RBOT stock listed?
RBOT stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for VICARIOUS SURGICAL INC-A stock?
9 analysts have analysed RBOT and the average price target is 10.2 USD. This implies a price increase of 79.26% is expected in the next year compared to the current price of 5.69. Check the VICARIOUS SURGICAL INC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VICARIOUS SURGICAL INC-A worth?
VICARIOUS SURGICAL INC-A (RBOT) has a market capitalization of 33.86M USD. This makes RBOT a Nano Cap stock.
How many employees does VICARIOUS SURGICAL INC-A have?
VICARIOUS SURGICAL INC-A (RBOT) currently has 121 employees.
What are the support and resistance levels for VICARIOUS SURGICAL INC-A (RBOT) stock?
VICARIOUS SURGICAL INC-A (RBOT) has a resistance level at 6.64. Check the full technical report for a detailed analysis of RBOT support and resistance levels.
Should I buy VICARIOUS SURGICAL INC-A (RBOT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RBOT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RBOT, evaluating the profitability, health, valuation and growth aspects
- VICARIOUS SURGICAL INC-A (RBOT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VICARIOUS SURGICAL INC-A (RBOT) Sales and EPS estimates to see what analysts future expectations are.
- VICARIOUS SURGICAL INC-A (RBOT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VICARIOUS SURGICAL INC-A (RBOT) Insider and Institutional Ownership to learn about the owners and their transactions.
- VICARIOUS SURGICAL INC-A (RBOT) Stock Chart to make your own analysis
- VICARIOUS SURGICAL INC-A (RBOT) Latest news and press-releases to stay up to date.
Does VICARIOUS SURGICAL INC-A (RBOT) stock pay dividends?
RBOT does not pay a dividend.
When does VICARIOUS SURGICAL INC-A (RBOT) report earnings?
VICARIOUS SURGICAL INC-A (RBOT) will report earnings on 2025-11-10, after the market close.
What is the Price/Earnings (PE) ratio of VICARIOUS SURGICAL INC-A (RBOT)?
VICARIOUS SURGICAL INC-A (RBOT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.09).
What is the Short Interest ratio of VICARIOUS SURGICAL INC-A (RBOT) stock?
The outstanding short interest for VICARIOUS SURGICAL INC-A (RBOT) is 3.3% of its float. Check the ownership tab for more information on the RBOT short interest.
RBOT Technical Analysis
RBOT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RBOT. No worries on liquidiy or solvency for RBOT as it has an excellent financial health rating, but there are worries on the profitability.
RBOT Financial Highlights
Over the last trailing twelve months RBOT reported a non-GAAP Earnings per Share(EPS) of -10.09. The EPS increased by 2.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -145.82% | ||
| ROE | -258.54% | ||
| Debt/Equity | 0 |
RBOT Forecast & Estimates
9 analysts have analysed RBOT and the average price target is 10.2 USD. This implies a price increase of 79.26% is expected in the next year compared to the current price of 5.69.